Trigo-Rodríguez, M., Cárcel, S., Navas, A., Espíndola-Gómez, R., Garrido-Gracia, J. C., Esteban-Moreno, M. Á., . . . Merchante, N. (2023). Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial.
Citación estilo ChicagoTrigo-Rodríguez, Marta, et al. Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial. 2023.
Cita MLATrigo-Rodríguez, Marta, et al. Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial. 2023.
Precaución: Estas citas no son 100% exactas.